Reported Reactions

Adverse event reports that FDA received

  • Search
  • Watch list

August 2019 adverse event reports that FDA received in the month

What a report is

A report is not proof that the drug was the cause of the event.

FDA says:

Adverse event reports submitted to FDA do not undergo extensive validation or verification. Therefore, a causal relationship cannot be established between product and reactions listed in a report. While a suspected relationship may exist, it is not medically validated and should not be the sole source of information for clinical decision making or other assumptions about the safety or efficacy of a product. Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.

Source: openFDA, Drug Adverse Event Overview, section "Responsible use of the data". The site read the page on . The data have the reports that FDA received through .

FDA also says:

There is no certainty that the reported event (adverse event or medication error) was actually due to the product. FDA does not require that a causal relationship between a product and event be proven, and reports do not always contain enough detail to properly evaluate an event. The information in these reports has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of these events.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated.

Source: openFDA, Response of the drug event API (meta.disclaimer). The site read the page on .

Not medical advice. This site counts what was reported to FDA. Questions about a medicine or device belong with a pharmacist or clinician.

Reports received

In August 2019, FDA received 108,334 drug adverse event reports. In August 2018, FDA received 111,038.

In August 2019, FDA received 103,074 medical device reports. In August 2018, FDA received 102,352.

By drug reports received, August 2019 was number 11 of the 12 months of 2019. FDA received 118,524 drug reports a month on average in the 12 months before August 2019.

Receive date

A month is the month in which FDA first received the report, not the month of the event. A report about an event of an earlier year is in the month in which it came to FDA.

Data version

FAERS release of 29 Oct 2026. MAUDE release of 23 Oct 2026.

Drug reports, three years

Drug reports that FDA received each month, 36 months to August 2019
0100,000200,000201720182019

Drugs in the reports

The table has the 137 drug pages with 250 or more reports in August 2019. The rows are in order of name. A drug page with fewer reports is not in the table.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.

Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of . The site read the page on .

Drugs that the reports of August 2019 name as a suspect product, in order of name
DrugReports in the month
Abatacept261
Actemra803
Afinitor281
Aimovig915
Alprazolam293
Ambrisentan454
Amlodipine397
Amoxicillin340
Apixaban455
Arava529
Aspirin252
Atorvastatin273
Aubagio310
Avonex268
Bisoprolol292
Breo Ellipta251
Buprenorphine267
Cabometyx1,309
Capecitabine400
Carboplatin513
Cimzia369
Ciprofloxacin299
Cisplatin316
Clopidogrel284
Clozapine389
Clozaril266
Codeine303
Copaxone254
Cosentyx1,744
Cyclophosphamide888
Cytarabine347
Dexamethasone973
Diazepam271
Docetaxel457
Docetaxel Accord369
Doxorubicin399
Duodopa271
Dupixent1,139
Eligard852
Eliquis1,008
Emgality513
Enbrel2,486
Entresto1,033
Etanercept366
Etoposide339
Exparel376
Fluorouracil252
Furosemide551
Gabapentin548
Gilenya728
Humalog415
Humira3,557
Hydroxychloroquine432
Hydroxychloroquine sulfate340
Ibrance873
Ibuprofen521
Imbruvica615
Infliximab375
Ingrezza352
Insulin glargine288
Jakafi447
Jardiance390
Jeuveau283
Keytruda348
Lamotrigine442
Lansoprazole328
Lantus Solostar266
Leflunomide531
Levetiracetam653
Levofloxacin335
Loratadine317
Lyrica1,000
Makena254
Mavyret537
Metformin523
Methotrexate2,493
Methotrexate sodium696
Methylprednisolone318
Mirena503
Mirtazapine310
Morphine sulfate283
Mycophenolate mofetil415
Neulasta771
Nexium469
Nexplanon412
Nivolumab463
Ocrevus275
Olanzapine280
Omeprazole598
Opdivo369
Opsumit466
Orencia1,104
Otezla1,791
Oxaliplatin378
Paclitaxel315
Pantoprazole546
Pantoprazole sodium301
Paracetamol430
Plaquenil515
Pomalyst688
Pradaxa254
Praluent345
Prednisolone611
Prednisone1,697
Pregabalin291
Prevacid305
Prilosec287
Prolia579
Quetiapine283
Ramipril425
Remicade938
Remodulin303
Repatha809
Revlimid2,340
Rituxan561
Rituximab719
Rivaroxaban263
Sertraline324
Simponi483
Soliris477
Spironolactone258
Stelara688
Sulfasalazine608
Symdeko251
Tacrolimus513
Taltz304
Tecfidera778
Tramadol332
Trelegy Ellipta365
Trulicity702
Tymlos771
Tysabri411
Venclexta301
Vincristine420
Xarelto509
Xeljanz1,503
Zytiga364

Reaction terms in the reports

The table has the 117 reaction terms with 500 or more reports in August 2019. The rows are in order of name. One report can record more than one term.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.

Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of . The site read the page on .

Reaction terms that the drug reports of August 2019 record, in order of name
Reaction term (MedDRA) and plain meaningReports in the month
Abdominal discomfortstomach discomfort1,084
Abdominal distensiona bloated abdomen527
Abdominal painstomach or belly pain1,165
Abdominal pain upperupper stomach pain1,180
Accidental exposure to product623
Acute kidney injurysudden loss of kidney function1,156
Adverse drug reactiona harmful or unpleasant reaction (the term names a medicine)507
Alopeciahair loss1,699
Anaemialow red blood cells907
Anxietyanxiety1,339
Arthralgiajoint pain2,224
Astheniaweakness or lack of energy2,000
Asthmaasthma571
Atrial fibrillationan irregular heart rhythm501
Back painback pain1,276
Blood glucose increasedraised blood sugar reading1,023
Blood pressure increaseda raised blood pressure reading872
Cerebrovascular accidentstroke722
Chest discomfortchest discomfort542
Chest painchest pain833
Chillschills or shivering555
Chronic kidney diseaselong-term kidney disease677
Condition aggravatedthe condition being treated got worse1,728
Confusional stateconfusion886
Constipationconstipation1,097
Coughcough1,401
Deaththe patient died; cause not stated by this term4,169
Decreased appetitereduced appetite1,333
Dehydrationdehydration744
Depressionlow mood1,090
Device issuea problem with the device694
Diarrhoealoose or frequent stools4,025
Dizzinesslight-headedness or unsteadiness2,620
Drug hypersensitivityan allergic-type reaction (the term names a medicine)2,402
Drug ineffectivethe medicine did not work as expected7,953
Drug interactionan interaction between medicines1,049
Drug intolerancethe medicine was not tolerated949
Dyspnoeashortness of breath3,017
Erythemaskin redness870
Falla fall2,002
Fatiguetiredness4,494
Feeling abnormalfeeling odd or not right1,285
Foetal exposure during pregnancythe unborn baby was exposed to the medicine788
Gait disturbancedifficulty walking1,076
Haemoglobin decreasedlow haemoglobin530
Headachehead pain3,588
Hospitalisationadmission to hospital980
Hyperhidrosisexcessive sweating690
Hypersensitivityan allergic-type reaction1,074
Hypertensionhigh blood pressure1,106
Hypoaesthesianumbness794
Hypotensionlow blood pressure1,148
Inappropriate schedule of product administrationthe product was taken at the wrong times1,186
Incorrect dose administeredthe wrong dose was given1,066
Infectionan infection, type not specified869
Injection site painpain where the injection was given1,102
Insomniadifficulty sleeping1,219
Intentional product use issuedeliberate use not as intended628
Joint swellinga swollen joint792
Loss of consciousnesspassing out658
Malaisegeneral feeling of being unwell2,867
Malignant neoplasm progression738
Maternal exposure during pregnancythe mother took the medicine during pregnancy578
Memory impairmentmemory problems793
Migrainemigraine580
Muscle spasmsmuscle cramps972
Muscular weaknessmuscle weakness648
Musculoskeletal stiffnessstiffness in muscles or joints502
Myalgiamuscle pain802
Myocardial infarctionheart attack540
Nasopharyngitisa cold797
Nauseafeeling sick4,456
Neuropathy peripheralnerve damage in hands or feet565
Neutropenialow neutrophils, a type of white blood cell758
No adverse eventno adverse event was reported768
Off label useused for a purpose or in a way not on the label4,564
Oropharyngeal painsore throat520
Overdosea dose above the recommended amount566
Painpain, site not specified3,092
Pain in extremitypain in an arm or leg1,662
Palpitationsawareness of the heartbeat612
Paraesthesiatingling or pins and needles748
Peripheral swellingswelling of the arms or legs1,152
Platelet count decreasedlow platelet count537
Pneumonialung infection1,689
Product dose omissiona dose was missed2,503
Product quality issuea problem with the product itself644
Product storage errorthe product was stored wrongly667
Product use in unapproved indicationused for a purpose not on the label2,042
Product use issuea problem in how the product was used957
Pruritusitching1,828
Psoriasispsoriasis, a skin condition879
Pyrexiafever1,886
Rashskin rash2,299
Renal failurekidney failure748
Rheumatoid arthritisrheumatoid arthritis, an inflammatory joint disease976
Seizurea fit or convulsion866
Sepsisa severe body-wide response to infection649
Somnolencedrowsiness1,177
Swellingswelling606
Syncopefainting617
Therapeutic product effect decreased676
Therapeutic product effect incomplete1,028
Therapy cessation731
Thrombocytopenialow platelets573
Toxicity to various agentspoisoning or toxic effect of one or more substances760
Treatment failurethe treatment did not work532
Tremorshaking870
Urinary tract infectionbladder or urinary infection885
Urticariahives970
Vision blurredblurred vision570
Visual impairmentreduced vision749
Vomitingbeing sick2,727
Weight decreasedweight loss1,560
Weight increasedweight gain1,084
White blood cell count decreasedlow white cell count584
Wrong technique in product usage processthe product was used in the wrong way1,575

Devices in the reports

The table has the 43 device pages with 250 or more reports in August 2019. The rows are in order of name. A device page with fewer reports is not in the table.

FDA says:

MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices.

Source: openFDA, Manufacturer and User Facility Device Experience. The site read the page on .

Device brand names that the device reports of August 2019 name, in order of name
Brand nameReports in the month
530G Insulin Pump MMT-751LNAS356
530g Insulin Pump Mmt-751nas322
630G Insulin PUMP MMT-1715K 630G BLACK MG1,321
640G Insulin Pump MMT-1711K1,566
640G Insulin Pump MMT-1712K1,995
670G Insulin Pump MMT-1780KL424
Animas Vibe288
Bard Flat Mesh254
CapSureFix Novus Lead MRI SureScan906
Dexcom G5 Mobile Continuous Glucose Monitoring System2,378
Dexcom G6 Continuous Glucose Monitoring System4,419
EnCor Biopsy Probe863
Endo GIA282
Essure917
Freestyle Libre 14 Day313
Heartstart Mrx298
HeartWare Ventricular Assist System - Battery352
HeartWare Ventricular Assist System - Controller272
HeartWare Ventricular Assist System - Controller 2.0894
Inspira Smooth Silicone Gel Filled Breast Implant323
Inspira Textured Silicone Gel Filled Breast Implant407
Liberty Select Cycler Assy Non-Valuated343
LifeVest WCD 4000 System1,009
MENTOR MemoryGel Breast Implant656
MENTOR Smooth Round Moderate Profile261
Natura359
Octrode Lead Kit, 60cm Length388
Omnipod Insulin Management System668
OmniPod Insulin Pump388
Paradigm REAL-Time REVEL Insulin Infusion Pump MMT-723LNAS377
Perclose Proglide 6f Suture Mediated Closure Smc System336
Precision?255
Pump MMT-1780KPK 670G Pathway Black MG4,523
Spectrum Infusion Pump442
Sprint Quattro Secure S MRI SureScan351
Style 68 Saline Filled Breast Implant391
T Slim G5 System1,087
t:slim G4 system332
t:slim X2 Insulin Pump734
t:slim X2 Insulin Pump with Basal-IQ Technology4,227
Tendril Sts447
U By Kotex Unknown Tampon Menstrual Unscented Heb320
V60 Ventilator2,090

Cite this page

Reported Reactions. August 2019: adverse event reports received by FDA. https://reportedreactions.com/month/2019-08/ Source: U.S. Food and Drug Administration, openFDA Drug Adverse Event (FAERS) files, release of . Reports received through .

Where the data come from

The counts come from the openFDA Drug Adverse Event (FAERS) bulk files, release of 29 Oct 2026. The files have the reports that FDA received through 30 Jun 2026. A drug name is the name on the report. The site matches it to a brand name or a generic name of the National Drug Code Directory of 2 Nov 2026. A class is the pharmacologic class (EPC) of the FDA label.

The device counts come from the openFDA Device Adverse Event (MAUDE) bulk files, release of 23 Oct 2026. The files have the reports that FDA received through 30 Sep 2026. The site does not publish a report narrative, a lot number, a detail of a patient or the identity of a reporter. The record of FDA is the authority. See how the site counts reports, the data sources and the corrections page.

Questions

Can the count for August 2019 change?

Yes. FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases. This page has the count of the openFDA release of 29 Oct 2026: 108,334 drug reports.

Does a month with many reports mean that something occurred in that month?

Not by itself. The date is the date on which FDA received the report, not the date of the event. FDA says:

Many factors can influence whether or not an event will be reported, such as the time a product has been marketed and publicity about an event.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

How does a person report an adverse event?

FDA runs MedWatch, a program that takes voluntary reports from health professionals, patients and consumers. The guide on how to report has the links.